賽輪輪胎(601058.SH)擬定增募資不超24.8億元 投入全鋼載重子午線輪胎項目等
格隆匯4月14日丨賽輪輪胎(601058.SH)披露2020年非公開發行股票預案,本次非公開發行股票的數量為不超過8.00億股(含),未超過本次發行前公司總股本的30%,發行價格為3.10元/股。
本次非公開發行股票的發行對象為袁仲雪、瑞元鼎實、海南橡膠和新華聯共4名特定投資者。全部發行對象均擬以現金認購本次非公開發行的股份,認購的股份自本次非公開發行結束之日起十八個月內不得轉讓。
根據本次發行價格和發行數量計算,本次非公開發行募集資金總額不超過24.8億元,扣除發行費用後,募集資金淨額擬投入年產300萬套高性能智能化全鋼載重子午線輪胎項目及補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.